239 related articles for article (PubMed ID: 31383547)
1. Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study.
Höckel M; Wolf B; Schmidt K; Mende M; Aktas B; Kimmig R; Dornhöfer N; Horn LC
Lancet Oncol; 2019 Sep; 20(9):1316-1326. PubMed ID: 31383547
[TBL] [Abstract][Full Text] [Related]
2. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
Höckel M; Hentschel B; Horn LC
Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
[TBL] [Abstract][Full Text] [Related]
3. Vulvar field resection based on ontogenetic cancer field theory for surgical treatment of vulvar carcinoma: a single-centre, single-group, prospective trial.
Höckel M; Trott S; Dornhöfer N; Horn LC; Hentschel B; Wolf B
Lancet Oncol; 2018 Apr; 19(4):537-548. PubMed ID: 29530664
[TBL] [Abstract][Full Text] [Related]
4. Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields.
Wolf B; Ganzer R; Stolzenburg JU; Hentschel B; Horn LC; Höckel M
Gynecol Oncol; 2017 Aug; 146(2):292-298. PubMed ID: 28526168
[TBL] [Abstract][Full Text] [Related]
5. Pattern analysis of regional spread and therapeutic lymph node dissection in cervical cancer based on ontogenetic anatomy.
Höckel M; Horn LC; Tetsch E; Einenkel J
Gynecol Oncol; 2012 Apr; 125(1):168-74. PubMed ID: 22155677
[TBL] [Abstract][Full Text] [Related]
6. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
7. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
8. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis.
Höckel M; Horn LC; Manthey N; Braumann UD; Wolf U; Teichmann G; Frauenschläger K; Dornhöfer N; Einenkel J
Lancet Oncol; 2009 Jul; 10(7):683-92. PubMed ID: 19482513
[TBL] [Abstract][Full Text] [Related]
9. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
[TBL] [Abstract][Full Text] [Related]
10. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology.
Höckel M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S106-12. PubMed ID: 17727931
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
12. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis.
Höckel M; Wolf B; Hentschel B; Horn LC
Eur J Cancer; 2017 Jan; 70():99-110. PubMed ID: 27914244
[TBL] [Abstract][Full Text] [Related]
15. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
[TBL] [Abstract][Full Text] [Related]
16. Preservation of the mesureter to reduce urinary complications: analysis of data from the observational Leipzig School MMR study.
Wolf B; Espig O; Stolzenburg JU; Horn LC; Aktas B; Höckel M
BJOG; 2020 Jun; 127(7):859-865. PubMed ID: 32037645
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
18. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
[TBL] [Abstract][Full Text] [Related]
19. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.
Tsuruga T; Fujimoto A; Kawana K; Mori M; Hasumi Y; Kino N; Tomio K; Miura S; Tanikawa M; Sone K; Miyamoto Y; Ikeda Y; Kojima S; Adachi K; Nagasaka K; Matsumoto Y; Arimoto T; Oda K; Nakagawa S; Horie K; Yasugi T; Yokota H; Osuga Y; Fujii T
Int J Clin Oncol; 2016 Apr; 21(2):359-366. PubMed ID: 26438230
[TBL] [Abstract][Full Text] [Related]
20. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
